King Pharmaceuticals (KG-N) Stock Predictions - Stockchase
WATCH LIST
10
King Pharmaceuticals (KG-N)

ON STOCKCHASE SINCE Aug 2002

Acquired by Pfizer

biotechnology/pharmaceutical

King Pharmaceuticals

KG-N

0 watching          
Join the Discussion

King Pharmaceuticals (KG-N) SAVE Dec, 31, 1969, 7:00 pm

0.00 0 (100%)

This company is not ACTIVE.

What the experts are saying about KG-N



  • All
  • Filtered
Signal Opinion Expert
BUY
A potential takeover play. Has been a bit undermanaged and is very cheap.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
A potential takeover play. Has been a bit undermanaged and is very cheap.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
David King

Portfolio , Putnam Investments...

Price Price
$17.250
Owned Owned
Unknown

BUY
King Pharmaceuticals(KG-N) 

December 19, 2003

Technical support is $12.75. A lot of upside potential. Fair market value is $35/40. However, earnings forecast trend is in a decline.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Technical support is $12.75. A lot of upside potential. Fair market value is $35/40. However, earnings forecast trend is in a decline.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Ross Healy

Chairman, Strategic Analysis C...

Price Price
$14.680
Owned Owned
Unknown

PAST TOP PICK
King Pharmaceuticals(KG-N) 

September 25, 2003

(A top pick Aug 12/03. Up 3%.) Still likes. An outstanding value for investors to focus on.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(A top pick Aug 12/03. Up 3%.) Still likes. An outstanding value for investors to focus on.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Brian Acker, CA

Chief Exec, Acker Finley Inc....

Price Price
$15.250
Owned Owned
Yes

TOP PICK
King Pharmaceuticals(KG-N) 

September 15, 2003

Has great value. US Healthcare looks very inexpensive.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Has great value. US Healthcare looks very inexpensive.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Brian Acker, CA

Chief Exec, Acker Finley Inc....

Price Price
$16.120
Owned Owned
Yes

TOP PICK
King Pharmaceuticals(KG-N) 

September 3, 2003

Will be volatile. An OK company at a bargain price. Good risk/reward.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Will be volatile. An OK company at a bargain price. Good risk/reward.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Arender,

Unknown, Unknown...

Price Price
$14.200
Owned Owned
Yes

WEAK BUY
King Pharmaceuticals(KG-N) 

August 22, 2003

Generic drug makers have been on quite a role.A good group to have exposure to.This company has FCC and business model problems.Risky.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Generic drug makers have been on quite a role.A good group to have exposure to.This company has FCC and business model problems.Risky.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Matt Barasch

US Portfol, RBC Asset Management...

Price Price
$13.970
Owned Owned
Unknown

TOP PICK
King Pharmaceuticals(KG-N) 

August 12, 2003

(Was a top pick on July 14, 2003.Up 15%.)Still likes.Good earnings. Came out with a relatively good performance report.Got hit by a sudden move of defense money moving into cyclical areas.Got too cheap.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(Was a top pick on July 14, 2003.Up 15%.)Still likes.Good earnings. Came out with a relatively good performance report.Got hit by a sudden move of defense money moving into cyclical areas.Got too cheap.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Brian Acker, CA

Chief Exec, Acker Finley Inc....

Price Price
$13.920
Owned Owned
Yes

TOP PICK
Systems indicate a top pick. Cheap and has earnings.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Systems indicate a top pick. Cheap and has earnings.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Brian Acker, CA

Chief Exec, Acker Finley Inc....

Price Price
$16.250
Owned Owned
Unknown

DON'T BUY
King Pharmaceuticals(KG-N) 

November 7, 2002

Fundamentally should be good, but the stock languishes.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Fundamentally should be good, but the stock languishes.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Brian Acker, CA

Chief Exec, Acker Finley Inc....

Price Price
$15.910
Owned Owned
Unknown

BUY
King Pharmaceuticals(KG-N) 

August 16, 2002

Cheap/ Good growth prospects. Only own a small portion in your portfolio.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Cheap/ Good growth prospects. Only own a small portion in your portfolio.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Robert Floyd

President, R A Floyd Management...

Price Price
$19.380
Owned Owned
Unknown

Showing 1 to 10 of 10 entries
Successfully Saved Company
Successfully Saved Company
1+
JOIN THE DISCUSSION
1 comments in the last 7 days